AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 194 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $794,000 | -40.3% | 39,654 | -41.9% | 0.00% | – |
Q2 2018 | $1,331,000 | +389.3% | 68,250 | +405.5% | 0.00% | – |
Q1 2018 | $272,000 | -71.6% | 13,501 | -74.1% | 0.00% | – |
Q2 2017 | $957,000 | -73.8% | 52,037 | -67.8% | 0.00% | -100.0% |
Q1 2017 | $3,648,000 | +116.1% | 161,739 | +233.5% | 0.00% | – |
Q4 2016 | $1,688,000 | -84.0% | 48,499 | -74.8% | 0.00% | -100.0% |
Q1 2015 | $10,529,000 | -0.7% | 192,626 | -22.6% | 0.00% | 0.0% |
Q4 2014 | $10,606,000 | +1.4% | 248,861 | -24.1% | 0.00% | 0.0% |
Q3 2014 | $10,464,000 | +54.9% | 327,940 | +0.6% | 0.00% | +50.0% |
Q2 2014 | $6,756,000 | +19.7% | 326,060 | +11.8% | 0.00% | 0.0% |
Q1 2014 | $5,645,000 | -32.8% | 291,760 | -15.7% | 0.00% | 0.0% |
Q4 2013 | $8,401,000 | +23.7% | 346,152 | +9.5% | 0.00% | 0.0% |
Q3 2013 | $6,793,000 | -13.8% | 316,230 | -10.7% | 0.00% | -33.3% |
Q2 2013 | $7,881,000 | – | 354,230 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 4,390,000 | $33,584,000 | 1.92% |
Bleichroeder LP | 1,299,994 | $9,945,000 | 1.76% |
ARMISTICE CAPITAL, LLC | 4,120,000 | $31,518,000 | 1.38% |
Palo Alto Investors LP | 2,959,587 | $22,641,000 | 1.36% |
Permanens Capital L.P. | 359,461 | $2,750,000 | 1.04% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 31,607 | $242,000 | 0.19% |
BOOTHBAY FUND MANAGEMENT, LLC | 348,000 | $2,662,000 | 0.18% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 795,611 | $6,086,000 | 0.07% |
Teza Capital Management LLC | 23,269 | $178,000 | 0.04% |
Livforsakringsbolaget Skandia, Omsesidigt | 38,800 | $297,000 | 0.03% |